West Pharmaceutical Services, Inc.

WST Healthcare Medical Instruments & Supplies

West Pharmaceutical Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.1 billion, up 6.25% from fiscal 2024. In the quarter to June 2026, revenue grew 13.8%, EPS grew 19.2%, free cash flow fell 20.7% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

382.92 0.10 −0.03%
Market cap
$27.0B
P/E
48.7×
Fwd P/E
37.3×
Dividend yield
0.23%
F-score
8/9
Altman Z
13.89
Beneish M
−2.79
Dividend safety
100/100

West Pharmaceutical Services, Inc. (WST) P/B ratio

Alert me on P/B ratio

As of 16 October 2026, West Pharmaceutical Services, Inc. (WST) trades at a P/B ratio of 9.1×. Over the past ten years it has ranged from 3.6× (February 2015) to 17.1× (September 2021); the current reading is higher than 70% of that period. That is above the Medical Instruments & Supplies industry median of 2.5× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 6.3× (29.74%)
FY2024 8.9× (0.87%)
FY2023 9.0× 38.44%
FY2022 6.5× (56.53%)
FY2021 14.9× 32.35%
FY2020 11.3× 59.66%
FY2019 7.1× 36.29%
FY2018 5.2× (9.69%)
FY2017 5.7× 4.18%
FY2016 5.5× 30.22%

Quarterly newest first

Period P/B ratio Change
Jun 2026 8.5× 40.86%
Mar 2026 6.0× (3.65%)
Dec 2025 6.3× 0.91%
Sep 2025 6.2× 15.09%
42 more quarters

Against its own ten years

Low 3.6× High 17.1×
Ten-year median 6.9×
Current reading's percentile 67

P/B ratio against peers

Company P/B ratio
COO The Cooper Companies, Inc. compare 1.3×
ALC Alcon compare 1.5×
MDLN Medline Inc. compare 1.6×
BAX Baxter International Inc. compare 2.1×
BDX Becton, Dickinson and Company compare 2.2×
SOLV Solventum Corporation compare 3.1×
RGEN Repligen Corporation compare 4.7×
RMD ResMed Inc. compare 5.3×
WST West Pharmaceutical Services, Inc. 9.1×
Medical Instruments & Supplies industry median 2.5×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on WST